413 POSTER A phase I dose escalation study of oral SB939...

413 POSTER A phase I dose escalation study of oral SB939 when administered thrice weekly (every other day) for 3 weeks in a 4-week cycle in patients with advanced solid malignancies

W.P. Yong, B.C. Goh, K. Ethirajulu, P. Yeo, O. Otheris, S.M. Chao, R. Soo, W.L. Yeo, E. Seah, J. Zhu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72347-4
File:
PDF, 61 KB
english, 2008
Conversion to is in progress
Conversion to is failed